Jump to navigation
STEM CELLS | STEM CELLS Translational Medicine
Researchers discover that TIMP3 release from MSCs can reduce the neurocognitive decline observed after traumatic brain injury
Studies into cell density and consequent metabolic alterations may enhance the clinical potential of human mesenchymal stem cells.
Researchers discover a potential means to enhance the therapeutic potential of MSCs by inhibiting their entrapment in the lungs.
A new study in a rat model suggests that infusions of MSCs could counteract many of the signs of normal aging.
Researchers begin to unravel the molecular responses to cell transplantation in the hope of improving treatment for retinal degeneration.
Boosting homing in mesenchymal stem cells to the mouse gut leads to an unexpected reduction in their pro-regenerative effects.
Researchers find that the placement of a stem cell-fibrin patch on the injured heart promotes the improvement of cardiac function
First-in-human case demonstrates that MAPC transplantation after liver transplantation is feasible and safe and may represent and new method of moderating immune responses
Detailed analysis of the oxygen sensing and metabolic signaling pathways may improve the therapeutic potential of mesenchymal stem cell populations
Stem cells derived from the human placenta promote neurological recovery following spina bifida surgery in an ovine model
The Stem Cells Portal is a shared platform for the STEM CELLS and STEM CELLS Translational Medicine sister journals, providing up-to-the-minute coverage of the latest research from bench science and developments to clinical applications.
STEM CELLS Translational Medicine is the official journal partner of
STEM CELLS Translational Medicine is the official journal of
STEM CELLS is the official journal of
Copyright © 2018